Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2023

Nov 9, 2023

30718_dirs_2023-11-09_b6c72d86-307c-481f-991c-687aea643af9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-11-01

Reporting Person: Geist William (PRESIDENT, PROTEIN SCIENCES)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-11-01 Restricted Stock Units $ A 19823 Acquired Common Stock (19823) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: This amendment is being filed solely to correct a typographical error in the number of restricted stock units granted.

F3: 9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025.